New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 24, 2014
12:07 EDTISIS, P, UPS, ARWR, HLF, GILD, AAPL, NUSOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday following reports on the state of manufacturing in the U.S., China and the European Union. The Purchasing Managers' Indexes, or PMIs, showed that manufacturing activity contracted last month in China but that it had expanded again in the U.S. and the EU. ECONOMIC EVENTS: In the U.S., Markit's manufacturing PMI for March fell to 55.5 from February's 57.1 reading. The reading was 1 point below the consensus forecast, but was still strongly in expansionary territory, as 50 is the dividing line between expansion and contraction. In China, Markit's flash PMI came in at 48.1, falling short of expectations for a 48.7 reading. In Europe, the PMI for the euro area as a whole came in at 53.2, which was just below last month's 32-month high reading of 53.3. COMPANY NEWS: Shares of Nu Skin Enterprises (NUS) surged nearly 19% near midday after the company's China business was penalized only $540,000 for direct sales of certain products. Nu Skin said it is already taking steps to correct the issues raised in the AIC reviews and that it is not aware of any other material enforcement investigations currently pending in China. Research firm Deutsche Bank said it expects Nu Skin to announce a "significant" share repurchase program over the next several quarters after the China investigation was resolved with "modest" fines. Deutsche thinks today's news lifts an overhang on Nu Skin and keeps a Buy rating on the stock with a $110 price target. Meanwhile shares of Nu Skin's multi-level marketing peer Herbalife (HLF), which has also been accused of impropriety in China, are up about 8%. Herbalife had its own news this morning as well, as it announced that it has amended and restated its agreement with Carl Icahn and will nominate three new Icahn designees for election to the company’s board. MAJOR MOVERS: Among the notable gainers was MicroVision (MVIS), which jumped 20% after announcing that it has agreed to supply customized PicoP display modules to shipping giant UPS (UPS). Also higher was Symantec (SYMC), which rose 2% after research firm BMO Capital upgraded the stock and said it believes all strategic options, including a sale or divestiture of underperforming assets, will be considered following the company's recent termination of its CEO. Among the noteworthy losers was Arrowhead Research (ARWR), which dropped more than 15%. Research firm Piper Jaffray attributed the move lower to competitor ISIS Pharmaceuticals (ISIS) having announced preclinical data on its own antisense compound targeting hepatitis B virus, which is a clinical area that Arrowhead is also exploring. A number of other biotechnology companies' shares were also lower, with Oppenheimer attributing the continued weakness in the sector to investor concerns that were sparked by a letter sent Friday by several members of Congress to Gilead (GILD) regarding the price of its Hepatits C drug, Sovaldi. Also lower were shares of Internet radio company Pandora (P), which slid almost 9% after Billboard reported on Friday that Apple (AAPL) is considering launching a new music service and is also weighing a new iTunes app for Android smartphones. INDEXES: Near midday, the Dow was down 52.55, or 0.32%, to 16,250.22, the Nasdaq was down 66.01, or 1.54%, to 4,210.78, and the S&P 500 was down 12.25, or 0.66%, to 1,854.27.
News For NUS;HLF;P;AAPL;ARWR;ISIS;GILD;UPS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
January 13, 2015
16:00 EDTGILD, AAPLOptions Update; January 13, 2015
iPath S&P 500 VIX Short-Term Futures up 66c to 34.42. Option volume leaders: AAPL JNJ CELG WFM TSLA TWTR AMZN GILD according to Track Data.
15:55 EDTAAPLGoPro weakness due to Apple camera patent news is overdone, says Barclays
Subscribe for More Information
12:33 EDTAAPLApple granted patent for remote-controlled camera system, Patently Apple says
Subscribe for More Information
12:15 EDTGILDExpress Scripts CEO says Gilead relationship 'important' going forward
Express Scripts (ESRX) CEO George Paz at the J.P. Morgan Healthcare Conference said his company's relationship with Gilead (GILD) is "important" going forward. Paz said his company's goal is not to exclude drugs. He continues to discuss Express Scripts's deal with AbbVie (ABBV) and the company's goal of saving clients money with regards to healthcare costs.
12:10 EDTGILDExpress Scripts CEO says 'never stopped talking to Gilead'
Subscribe for More Information
11:43 EDTGILDGilead says negotiations ongoing with major U.S. payors for Harvoni
Subscribe for More Information
11:10 EDTGILDGilead drops, levels to watch
Subscribe for More Information
10:59 EDTAAPLApple rises after Credit Suisse, Canaccord hike iPhone estimates
Shares of Apple (AAPL) are climbing after two research firms issued upbeat notes on the company in notes to investors today. WHAT'S NEW: Credit Suisse analyst Kulbinder Garcha upgraded Apple to Outperform from Market Perform. The company should sell 215M iPhones in both fiscal 2015 and fiscal 2016, Garcha estimated. Meanwhile, Apple's gross margins are being boosted by the increased popularity of both its 64 GB memory phones and of the IPhone 6 Plus, the analyst stated. Garcha increased his earnings per share estimate for the iPhone maker by 18% in fiscal 2015 and 20% in fiscal 2016. Additionally, the firm believes excessive net cash levels indicate a new $200B return program should occur. The analyst thinks the shares can reach $130 at least. After analyzing surveys in the U.S. that took place in December and into January, Canaccord analyst T. Michael Walkley said the surveys showed strong demand and market share gains for the new iPhones. The analyst increased his iPhone estimates for Apple's December quarter, as well as his estimates for the company's overall December quarter results. The increases were based on the positive demand trends, particularly for models with higher memory levels and prices, Walkley stated. He expects these positive trends to continue and reiterated a $135 price target and Buy rating on the shares. PRICE ACTION: In mid-morning trading, Apple climbed $3.39, or 3.1%, to $112.64.
10:00 EDTAAPLOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:36 EDTAAPL, GILDActive equity options trading
Active equity options trading according to Track Data: AAPL AMD AA TWTR GILD C CELG TSLA GOOG
09:07 EDTAAPLOn The Fly: Pre-market Movers
HIGHER: Apple (AAPL), up 1.4% after Credit Suisse upgraded Apple to Outperform and raised its iPhone volume estimates again... Best Buy (BBY), up 2.8% after being upgraded to Buy from Neutral at Goldman... SunPower (SPWR), up 2.6% after being upgraded to Outperform at Credit Suisse... Alcoa (AA), up 2% after Q4 results beat expectations. RISING AFTER GUIDANCE: Pharmacyclics (PCYC), up 17.5%... CTI BioPharma (CTIC), up 8.3%... Emulex (ELX), up 15.5%... ARIAD (ARIA), up 2.6%. LOWER: ChannelAdvisor (ECOM), down 42% following preliminary fourth quarter revenue guidance and after receiving multiple analyst downgrades... Antares Pharma (ATRS), down 7.7% after the FDA recommended that the company create a larger safety database for its clinical development program for QuickShot Testosterone.
07:42 EDTGILDJPMorgan to hold a conference
33rd Annual Healthcare Conference is being held in San Francisco on January 12-15 with webcasted company presentations to begin on January 13 at 10:30 am; not all company presentations may be webcasted. Webcast Link
07:36 EDTAAPLApple survey suggests demand remains strong, says Canaccord
Subscribe for More Information
07:18 EDTAAPLQuanta ramps up production of 12-inch MacBook Air, DigiTimes reports
Subscribe for More Information
06:21 EDTAAPLApple upgraded at Credit Suisse
As previously reported, Credit Suisse upgraded Apple to Outperform from Neutral. The firm raised iPhone volume estimates again to 215M units for both FY15/16 and sees $10 EPS power in CY16 based on a solid and sustainable iPhone trends combined with a muted response from Samsung. Additionally, the firm believes excessive net cash levels indicate a new $200B return program should occur. Price target raised to $130 from $110.
06:20 EDTAAPLApple supplier shows 'unbreakable' smartphone with sapphire display, WSJ says
Subscribe for More Information
06:18 EDTAAPLSilicon Valley shuttle drivers looking to unionize, USA Today reports
Subscribe for More Information
06:09 EDTAAPLApple implied volatility of 38 at upper end of index mean range
Subscribe for More Information
06:06 EDTAAPLApple upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
06:01 EDTHLFStocks with implied volatility above IV index mean; HLF YHOO
Stocks with implied volatility above IV index mean; Herbalife (HLF) 115, Yahoo (YHOO) 52 according to iVolatility.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use